AAIC 2026: Synaptic Dysfunction and Neural Circuit Alterations

Conference: AAIC 2026 | Dates: July 12-15, 2026 | Location: Excel London, UK

Overview

Synaptic dysfunction and neural circuit alterations represent fundamental pathological features of Alzheimer's disease (AD), accounting for the progressive cognitive decline that characterizes the disorder. At AAIC 2026, extensive research is presented on the mechanisms by which amyloid-beta (Aβ), tau, and other disease-related factors disrupt synaptic integrity and impair neural network function. These changes begin years before clinical symptoms manifest and correlate more strongly with cognitive impairment than traditional neuropathological markers such as plaque or tangle burden[@selkoe2024].

The synapse serves as the primary site of neural communication and is exquisitely vulnerable to the molecular insults that define AD. Aβ oligomers bind directly to synapses, triggering cascades that lead to spine loss, receptor dysfunction, and impaired plasticity[@palop2010]. Tau pathology spreads through synaptic connections, propagating dysfunction across neural networks[@busche2022]. The combined effects of these pathological processes disrupt the delicate balance of excitation and inhibition that underlies proper circuit function, leading to network hyperexcitability, impaired oscillations, and ultimately cognitive failure[@chen2023].

This page provides comprehensive coverage of synaptic plasticity mechanisms, neural network dysfunction, memory circuit impairment, dendritic spine changes, and therapeutic implications for addressing synaptic dysfunction in AD.

Conference: AAIC 2026 | Dates: July 12-15, 2026 | Location: Excel London, UK

Overview

Synaptic dysfunction and neural circuit alterations represent fundamental pathological features of Alzheimer's disease (AD), accounting for the progressive cognitive decline that characterizes the disorder. At AAIC 2026, extensive research is presented on the mechanisms by which amyloid-beta (Aβ), tau, and other disease-related factors disrupt synaptic integrity and impair neural network function. These changes begin years before clinical symptoms manifest and correlate more strongly with cognitive impairment than traditional neuropathological markers such as plaque or tangle burden[@selkoe2024].

The synapse serves as the primary site of neural communication and is exquisitely vulnerable to the molecular insults that define AD. Aβ oligomers bind directly to synapses, triggering cascades that lead to spine loss, receptor dysfunction, and impaired plasticity[@palop2010]. Tau pathology spreads through synaptic connections, propagating dysfunction across neural networks[@busche2022]. The combined effects of these pathological processes disrupt the delicate balance of excitation and inhibition that underlies proper circuit function, leading to network hyperexcitability, impaired oscillations, and ultimately cognitive failure[@chen2023].

This page provides comprehensive coverage of synaptic plasticity mechanisms, neural network dysfunction, memory circuit impairment, dendritic spine changes, and therapeutic implications for addressing synaptic dysfunction in AD.

Pathway / Mechanism Diagram

Synaptic Plasticity Mechanisms in Alzheimer's Disease

Long-Term Potentiation Impairment

Long-term potentiation (LTP) represents the cellular basis for learning and memory, and its impairment is a hallmark of synaptic dysfunction in AD[@hernandez2023]. LTP requires the coordinated activity of NMDA receptors, AMPA receptors, and downstream signaling molecules including CaMKII, which are all disrupted by Aβ and tau pathology.

NMDA Receptor Dysfunction:

• Aβ promotes NMDA receptor internalization, reducing calcium influx necessary for LTP induction[@snyder2005]
• Altered subunit composition impairs the molecular coincidence detector function
• Tau mislocalization to dendritic spines interferes with NMDA receptor signaling

• Aβ accelerates AMPA receptor internalization through clathrin-dependent mechanisms[@hsieh2006]
• Reduced synaptic AMPA receptor content impairs the expression phase of LTP
• PSD-95 disruption affects the scaffolding required for proper receptor positioning

• CaMKII autophosphorylation is reduced in AD models and human tissue
• CREB-mediated transcription, critical for LTP maintenance, is impaired
• Actin cytoskeleton regulators are targeted by pathological proteins

Long-Term Depression Alterations

While LTP is impaired, certain forms of long-term depression (LTD) may be enhanced in AD, contributing to synaptic weakening and elimination[@forner2021]:

• Aβ oligomers promote internalization of AMPA receptors through LTD-like mechanisms
• NMDA receptor-dependent LTD is exaggerated in the presence of Aβ
• mGluR-dependent LTD pathways are dysregulated

Homeostatic Plasticity Failure

Homeostatic mechanisms that maintain synaptic equilibrium are compromised in AD:

• Synaptic scaling responses to activity changes are blunted
• Homeostatic depression fails to compensate for hyperactivity
• Structural homeostasis is disrupted, leading to spine loss

Neural Network Dysfunction in Alzheimer's Disease

Network Hyperexcitability

Paradoxically, despite overall synaptic loss, neural networks in AD exhibit hyperexcitability[@zott2019]:

Mechanisms:

• Compensation for reduced synaptic input leads to elevated firing rates
• Excitatory-inhibitory balance shifts toward excitation
• Loss of inhibitory interneurons contributes to disinhibition
• Aβ directly increases neuronal excitability through various mechanisms

• Increased seizure activity in AD patients
• Accelerated tau pathology spread through hyperactive neurons
• Network instability and impaired information processing
• Contributes to cognitive dysfunction beyond pure synapse loss

Oscillation Disruption

Neural oscillations provide the temporal framework for information processing and are disrupted in AD:

Theta Oscillations (4-8 Hz):

• Reduced theta power correlates with memory impairment
• Phase precession of place cells is disrupted
• Impaired navigation and spatial memory

• Gamma power is reduced in AD models and patients
• Theta-gamma coupling is disrupted
• Feature binding and memory consolidation are impaired

• Phase-amplitude coupling between theta and gamma is compromised
• Temporal coordination of neural ensembles is disrupted
• Information coding in hippocampal circuits is impaired

Default Mode Network Alterations

The default mode network (DMN), active during rest and memory consolidation, shows characteristic alterations in AD:

• Reduced DMN connectivity correlates with cognitive decline
• Aβ deposition in DMN hubs may drive network dysfunction
• Temporal patterns of DMN activity are disrupted
• Forward and backward connectivity changes distinguish early AD

Entorhinal-Hippocampal Circuit Dysfunction

The entorhinal cortex serves as the gateway between the neocortex and hippocampus, and its dysfunction represents an early event in AD[@hernandez2024]:

Layer II Vulnerability:

• Layer II neurons are selectively vulnerable to tau pathology
• Grid cell and place cell dysfunction emerges early
• Disconnection from hippocampal formation impairs memory encoding

• Synaptic loss in the perforant path is an early pathological change
• Information flow from entorhinal cortex to dentate gyrus is impaired
• Pattern separation capacity is reduced

• CA1 pyramidal neurons show early tau pathology
• CA3 recurrent collaterals are vulnerable
• Dentate gyrus granule cell function is compromised

Memory Circuit Impairment

Hippocampal Circuit Dysfunction

The hippocampus is critical for declarative memory formation and is profoundly affected in AD[@khan2024]:

CA1 Circuitry:

• CA1 pyramidal neurons are selectively vulnerable to tau pathology
• Schaffer collateral synapses onto CA1 exhibit impaired LTP
• Temporal ordering of events is disrupted

• Recurrent collateral connections are lost
• Pattern completion capacity is impaired
• Auto-associative memory storage is compromised

• Adult neurogenesis declines in AD
• Pattern separation capacity is reduced
• Mossy fiber pathway function is impaired

Cortico-Hippocampal Interactions

Communication between cortex and hippocampus is disrupted:

• Reduced effective connectivity from entorhinal cortex to hippocampus
• Impaired retrieval of cortical memories through hippocampal-cortical loops
• Consolidation of episodic memories is compromised

Prefrontal Cortex Dysfunction

Executive function and working memory circuits are impaired in AD:

• Prefrontal cortical connectivity is reduced
• Theta synchronization between prefrontal cortex and hippocampus is impaired
• Decision-making and cognitive control are affected

Temporal Lobe Circuitry

Semantic memory circuits in the temporal lobe are affected:

• Perirhinal and parahippocampal cortices show early pathology
• Object recognition memory is impaired
• Familiarity-based memory decisions are disrupted

Dendritic Spine Changes in Alzheimer's Disease

Spine Loss Patterns

Dendritic spines, the primary sites of excitatory synaptic contact, are lost in AD[@siskova2009]:

Quantitative Changes:

• Spine density reductions of 25-50% in affected brain regions
• Progressive loss correlates with cognitive decline
• Early loss in hippocampal CA1 and cortical layer II/III

• Hippocampal CA1 pyramidal neurons show early spine loss
• Layer V cortical pyramidal neurons are affected
• Specific subtypes of spines are preferentially lost

Morphological Alterations

Beyond quantitative loss, spine morphology is altered[@spires2005]:

Mushroom Spines:

• Large, stable spines are reduced
• Loss of mature, stable synaptic contacts
• Remaining spines may shrink

• Highly plastic spines are disproportionately lost
• Impaired capacity for activity-dependent remodeling
• Learning-related spine formation is blunted

• Increased proportion of immature spines
• Defective spinogenesis
• Impaired synaptic formation

Mechanisms of Spine Dysfunction

Amyloid-Beta Effects:

• Aβ oligomers bind directly to synapses, triggering internalization pathways
• NMDA receptor activation promotes spine elimination through PAK pathway[@bitner2010]
• Actin cytoskeleton regulators are targeted

• Hyperphosphorylated tau mislocalizes to dendritic spines[@hoover2010]
• Tau in spines disrupts NMDA receptor signaling
• Reduces AMPA receptor surface expression
• Aβ-induced spine loss requires tau[@roberson2007]

• Calcium dysregulation triggers spine-eliminating pathways
• Reduced BDNF signaling affects spine maintenance
• Impaired local protein synthesis in spines

Spines as Therapeutic Targets

Preserving and restoring spines represents a key therapeutic strategy:

• NMDA receptor modulators can protect spines
• Actin cytoskeleton stabilization approaches
• BDNF signaling enhancement
• Anti-Aβ immunotherapies may protect spines indirectly

Therapeutic Implications

Synapse-Targeted Interventions

Multiple approaches aim to preserve or restore synaptic function[@masliah2021]:

Small Molecule Strategies:

• NMDA receptor modulators (glycine site modulators)
• AMPA receptor positive allosteric modulators (AMPAkines)
• PDE inhibitors to enhance plasticity-related signaling
• Muscarinic M1 agonists to enhance cholinergic signaling

• BDNF delivery through various modalities
• TrkB agonist development
• NGF for basal forebrain cholinergic neurons[@nagahara2011]

• Small molecules promoting spinogenesis
• Activity-dependent stimulation protocols
• Environmental enrichment approaches

Disease-Modifying Approaches

Targeting underlying pathology provides indirect synaptic protection:

Anti-Amyloid Therapies:

• Monoclonal antibodies (lecanemab, donanemab)
• Active vaccination approaches
• Small molecule aggregation inhibitors

• Tau aggregation inhibitors
• Anti-tau antibodies
• Tau degradation enhancers

• Simultaneous targeting of Aβ and tau may provide synergistic benefits
• Addressing multiple aspects of synaptic dysfunction
• Personalized approaches based on biomarker profiles

Network-Level Interventions

Restoring proper network function is an emerging therapeutic strategy:

Non-invasive Brain Stimulation:

• Transcranial magnetic stimulation (TMS)
• Transcranial direct current stimulation (tDCS)
• Targeted stimulation of specific networks

• Targeting hippocampal circuits
• Fornix stimulation to enhance memory function
• Experimental approaches in early AD

• Cognitive training to enhance network function
• Physical exercise to promote synaptic plasticity
• Sleep optimization for synaptic homeostasis

Cross-Links to Existing Mechanism Pages

This content is complemented by detailed coverage in the following NeuroWiki pages:

• [Synaptic Dysfunction in Neurodegenerative Diseases](/mechanisms/synaptic-dysfunction) — Comprehensive mechanism page covering synaptic biology, molecular pathways, and therapeutic approaches
• [AAIC 2026: Synaptic Function Preservation](/events/aaic-2026/synaptic-function-preservation) — Additional AAIC 2026 coverage on synaptic protective strategies
• [Dendritic Spines in Neurodegeneration](/mechanisms/dendritic-spines) — Detailed coverage of spine structure, dysfunction mechanisms, and therapeutic implications
• [Alzheimer Hippocampal Circuit](/circuits/alzheimer-hippocampal-circuit) — Detailed coverage of hippocampal anatomy, circuit function, and AD pathology
• [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity-mechanisms) — In-depth coverage of LTP, LTD, and plasticity mechanisms
• [Synaptic Loss in Alzheimer's Disease](/mechanisms/synaptic-loss-ad) — Specific coverage of synaptic loss mechanisms in AD
• [Neural Circuit Disruption](/mechanisms/neural-circuit-disruption) — Network-level dysfunction across neurodegenerative diseases
• [BDNF Signaling Pathway](/mechanisms/bdnf-signaling-pathway) — Neurotrophic factor pathways important for synaptic health
• [Long-Term Potentiation Mechanism](/mechanisms/long-term-potentiation) — Detailed LTP coverage

Notable AAIC 2026 Sessions

Symposia

• "Synaptic Failure in Alzheimer's Disease: From Molecules to Networks"
• "Neural Circuit Dysfunction: New Insights from Advanced Imaging"
• "Dendritic Spine Pathology: Mechanisms and Therapeutic Implications"
• "Network-Based Biomarkers for Early Detection and Treatment Monitoring"

Workshops

• "Measuring Synaptic Function in Clinical Trials"
• "Advanced Neuroimaging of Synaptic and Network Dysfunction"
• "Translational Models of Synaptic Plasticity Impairment"

Oral Presentations

• Novel therapeutic approaches targeting synaptic plasticity
• Network dysfunction biomarkers in early AD
• Results from clinical trials of synapse-protective compounds

Research Frontiers

Emerging Technologies

• Single-cell transcriptomics of synaptic dysfunction
• Super-resolution imaging of spine pathology
• In vivo two-photon microscopy of spine dynamics
• Human iPSC-derived neurons for synaptic studies

Novel Therapeutic Targets

• Synaptic adhesion molecules
• Postsynaptic density scaffolding proteins
• Presynaptic active zone proteins
• Synaptic mitochondrial function
• Local translation machinery

Biomarker Development

• Synaptic proteins in cerebrospinal fluid (neurogranin, SNAP-25)
• SV2A PET imaging for synaptic density
• Network-based biomarkers from fMRI/EEG
• Combination approaches for early detection

Conclusion

Synaptic dysfunction and neural circuit alterations represent core features of Alzheimer's disease pathophysiology that directly underlie cognitive impairment. The mechanisms range from molecular (Aβ and tau effects on receptors and spines) to circuit-level (network hyperexcitability and oscillation disruption), creating multiple opportunities for therapeutic intervention. AAIC 2026 highlights the importance of addressing synaptic dysfunction through both disease-modifying approaches targeting underlying pathology and direct synapticprotective strategies. The integration of biomarkers, advanced imaging, and targeted therapies offers hope for preserving cognitive function in Alzheimer's disease.

References